Shares of Hawkins, Inc. (NASDAQ:HWKN – Get Free Report) hit a new 52-week high on Tuesday . The stock traded as high as $108.85 and last traded at $108.40, with a volume of 15353 shares traded. The stock had previously closed at $105.87.
Analyst Ratings Changes
Separately, BWS Financial upped their target price on Hawkins from $74.00 to $96.00 and gave the stock a “buy” rating in a research note on Friday, May 17th.
Get Our Latest Stock Analysis on Hawkins
Hawkins Trading Up 2.8 %
Hawkins (NASDAQ:HWKN – Get Free Report) last posted its quarterly earnings data on Wednesday, May 15th. The specialty chemicals company reported $0.66 EPS for the quarter, missing the consensus estimate of $0.68 by ($0.02). Hawkins had a net margin of 8.20% and a return on equity of 19.41%. The firm had revenue of $223.02 million during the quarter, compared to analyst estimates of $217.49 million. On average, research analysts predict that Hawkins, Inc. will post 3.67 EPS for the current fiscal year.
Hawkins Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, June 14th. Investors of record on Friday, May 31st were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 0.59%. The ex-dividend date was Friday, May 31st. Hawkins’s dividend payout ratio is currently 17.83%.
Insider Activity at Hawkins
In related news, Director James A. Faulconbridge bought 1,800 shares of the company’s stock in a transaction on Thursday, June 6th. The stock was bought at an average cost of $87.56 per share, for a total transaction of $157,608.00. Following the acquisition, the director now directly owns 40,517 shares in the company, valued at $3,547,668.52. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, Director James A. Faulconbridge bought 2,000 shares of the company’s stock in a transaction on Monday, June 10th. The stock was bought at an average cost of $86.47 per share, for a total transaction of $172,940.00. Following the acquisition, the director now directly owns 44,017 shares in the company, valued at $3,806,149.99. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director James A. Faulconbridge bought 1,800 shares of the company’s stock in a transaction on Thursday, June 6th. The stock was bought at an average price of $87.56 per share, with a total value of $157,608.00. Following the completion of the acquisition, the director now owns 40,517 shares in the company, valued at $3,547,668.52. The disclosure for this purchase can be found here. In the last ninety days, insiders bought 5,100 shares of company stock valued at $442,998. 3.80% of the stock is owned by insiders.
Institutional Trading of Hawkins
Several large investors have recently added to or reduced their stakes in HWKN. American Century Companies Inc. grew its holdings in Hawkins by 51.1% in the 3rd quarter. American Century Companies Inc. now owns 119,740 shares of the specialty chemicals company’s stock valued at $7,047,000 after buying an additional 40,492 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of Hawkins by 2.4% during the 3rd quarter. Vanguard Group Inc. now owns 1,454,493 shares of the specialty chemicals company’s stock worth $85,597,000 after purchasing an additional 34,415 shares during the period. Raymond James & Associates grew its holdings in shares of Hawkins by 12.2% during the 4th quarter. Raymond James & Associates now owns 4,895 shares of the specialty chemicals company’s stock worth $345,000 after purchasing an additional 534 shares during the period. Pacer Advisors Inc. purchased a new position in shares of Hawkins during the 4th quarter worth $27,098,000. Finally, Values First Advisors Inc. grew its holdings in shares of Hawkins by 7.7% during the 4th quarter. Values First Advisors Inc. now owns 11,863 shares of the specialty chemicals company’s stock worth $835,000 after purchasing an additional 847 shares during the period. 69.71% of the stock is currently owned by hedge funds and other institutional investors.
Hawkins Company Profile
Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.
Further Reading
- Five stocks we like better than Hawkins
- What is a Death Cross in Stocks?
- ScottsMiracle-Gro Stock Blooms After Investor Day Optimism
- The Most Important Warren Buffett Stock for Investors: His Own
- Leading Beverage Company’s Stock Bubbles Higher: Rally Ahead
- How is Compound Interest Calculated?
- Can This Meme Stock Stage One Last Rally?
Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.